Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2011 February;59(1) > Minerva Cardioangiologica 2011 February;59(1):101-8

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

REVIEWS  


Minerva Cardioangiologica 2011 February;59(1):101-8

language: English

Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus

Piaggesi A., Vallini V., Iacopi E., Tedeschi A., Scatena A., Goretti C., Rizzo L.

Sezione Piede Diabetico, Unità Operativa Malattie del Metabolismo e Diabetologia, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italia


PDF  


Diabetic complications in the lower extremities, especially those secondary to diabetic macroangiopathy, have increasingly become a clinical emergency, given the high prevalence and progression of the disease. Until recently, the only approach to treating advanced stage disease was medical therapy and major amputation; however, the advent of revascularization procedures has radically improved the prognosis of patients with critical lower limb ischemia. In this setting, iloprost holds a dual position: as first-choice therapy in patients ineligible for revascularization and as complementary therapy in candidates for surgical or endovascular revascularization.

top of page

Publication History

Cite this article as

Corresponding author e-mail

piaggesi@immr.med.unipi.it